Laurus Labs Ltd.

Financial

	Laurus Labs	Neuland Laboratories	Granules India
Operational Metrics
Pharmaceutical Sector
Fermentation Capacity	250.0 KL	n/a	n/a
Number of ANDA's Filed in Europe	22.0	n/a	n/a
Number of ANDA's Approved in Europe	19.0	n/a	n/a
Number of ANDA's Filed in Canada	23.0	n/a	n/a
Number of ANDA's Approved by Canada	16.0	n/a	n/a
Number of ANDA's Filed in USA	43.0 .	n/a	85.0 .
Number of ANDA's Approved By USFDA	35.0 .	n/a	68.0 .
US DMF Filings	90.0 .	72.0 .	41.0 .
R&D as a % of Total Sales	4.6 %	4.15 %	5.3 %
Financials
5 yr Average ROE	18.77 %	14.95 %	17.11 %
5yr average Equity Multiplier	2.06	1.56	1.71
5yr Average Asset Turnover Ratio	0.71	0.74	0.83
5yr Avg Net Profit Margin	11.95 %	13.18 %	11.91 %
Price to Book	10.81	13.51	3.49
P/E	95.04	116.95	27.05
5yr Avg Cash Conversion Cycle	91.73 Days	38.21 Days	-44.08 Days
Inventory Days	114.71 Days	87.5 Days	72.16 Days
Days Receivable	120.6 Days	85.17 Days	47.23 Days
Days Payable	145.16 Days	118.14 Days	127.76 Days
5yr Average Interest Coverage Ratio	8.98	20.78	15.94
5yr Avg ROCE	22.73 %	17.63 %	21.96 %
5yr Avg Operating Profit Margin	24.36 %	21.01 %	21.18 %
5 yr average Debt to Equity	0.56	0.15	0.38
5yr CAGR Net Profit	-18.29 %	26.4 %	-1.81 %
5yr Average Return on Assets	8.99 %	9.87 %	10.0 %
Shareholdings
Promoter Holding	27.59 %	32.68 %	38.82 %
Share Pledged by Promoters	2.69 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.32 %	-3.54 %	-3.16 %
Change in Mutual Fund Holding (3 Yrs)	3.01 %	6.87 %	9.21 %

Business

	Laurus Labs	Neuland Laboratories	Granules India
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 41.0 Synthesis 31.0 Formulations 26.0 Bio 2.0 Ingredients 0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0 MCB 0 GGF 0 IBU ( Ibuprofen) 0 MF(Metformin) 0 Para 0	Product Wise Break-Up Synthesis 0 Formulations 0 Para 0 Active Pharmaceutical Ingredient (API) 0 GGF 0 MCB 0 Custom Manufacturing Solutions(CMS) 32.0 Formulations 60.0 Ingredients 0 MF(Metformin) 0 Bio 0 IBU ( Ibuprofen) 0 Others 8.0	Product Wise Break-Up Synthesis 0 Formulations 0 Paracetamol 46.0 Active Pharmaceutical Ingredient (API) 0 GGF 4.0 MCB 3.0 Custom Manufacturing Solutions(CMS) 0 Generic Drug Substances(GDS) 0 Ingredients 0 Metformin 22.0 Bio 0 Ibuprofen 10.0 Others 15.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 55.0 Europe 25.0 North America 20.0 India 0 USA 0 Canada 0 AMEA 0 Latin America 0	Location Wise Break-Up Rest of the World 10.4 India 30.39 Canada 0 North America 0 USA 29.35 Europe 29.86 Latin America 0 AMEA 0	Location Wise Break-Up Rest of the World 9.0 India 0 Canada 0 North America 0 USA 77.0 Europe 14.0 Latin America 0 AMEA 0